Yakira Capital Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Yakira Capital Management’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,537	Closed	-$447K	–	422
2023 Q1	$447K	Buy	+18,537	New	+$233K	0.11%	126

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Yakira Capital Management's PRVB Position: Q2 2023 in Review

Yakira Capital Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 18,537 shares — an estimated $447K sold.

Yakira Capital Management first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $447K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Yakira Capital Management reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Yakira Capital Management sold 18,537 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $447K.
Yakira Capital Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Yakira Capital Management's Provention Bio, Inc. Common Stock position peaked at $447K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Yakira Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.